Oncogenesis (journal)

{{Infobox journal

| title = Oncogenesis

| image =

| image_size =

| alt =

| caption =

| former_name =

| abbreviation = Oncogenesis

| bluebook =

| mathscinet =

| nlm =

| discipline = Oncology

| peer-reviewed =

| language = English

| editor = Jan Paul Medema

| publisher = Springer Nature

| country =

| history = 2012–present

| frequency = Weekly

| openaccess = Yes

| license =

| impact = 7.485

| impact-year = 2020

| ISSNlabel =

| ISSN =

| eISSN = 2157-9024

| CODEN =

| JSTOR =

| LCCN =

| OCLC = 958712217

| website = https://www.nature.com/oncsis/

| link1 = https://www.nature.com/oncsis/articles

| link1-name = Online

| link2 =

| link2-name =

| boxwidth =

}}

Oncogenesis is a peer-reviewed open access medical journal covering the molecular biology of cancer. It was established in 2012 by Douglas R. Green as a sister journal to Oncogene, of which Green was then editor-in-chief.{{cite journal | vauthors = Medema JP | title = Welcome to the next step for Oncogenesis | language = En | journal = Oncogenesis | volume = 3 | issue = 12 | pages = e130 | date = December 2014 | pmid = 25438076 | pmc = 4275560 | doi = 10.1038/oncsis.2014.46 }} New articles are published exclusively online by Springer Nature on a weekly basis.{{Cite web |url=https://www.nature.com/oncsis/authors-and-referees/authors |title=For Authors |website=Oncogenesis |language=en |access-date=2018-10-19}} The editor-in-chief is Jan Paul Medema (University of Amsterdam). According to the Journal Citation Reports, the journal has a 2020 impact factor of 7.485, ranking it 40th out of 242 journals in the category "Oncology".{{cite book |year=2021 |chapter=Journals Ranked by Impact: Oncology |title=2020 Journal Citation Reports |publisher=Clarivate Analytics |edition=Science |series=Web of Science|title-link=Journal Citation Reports }}